Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 761-768

  Arsenescu, Violeta ^a   Arsenescu, Razvan I ^a   King, Victoria ^a   Swanson, Hollie ^a   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adipocyte differentiation; Atyl hydrocarbon receptor; Ectopic lipid deposition; Obesity; Polychlorinated bipheyl

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ADIPOCYTOKINE; AROMATIC HYDROCARBON RECEPTOR; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYCHLORINATED BIPHENYL; POLYCHLORINATED BIPHENYL 77;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN 3T3; CELL STRUCTURE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT GAIN;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; ATHEROSCLEROSIS; BODY WEIGHT; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION; GLYCEROLPHOSPHATE DEHYDROGENASE; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; POLYCHLORINATED BIPHENYLS; PPAR GAMMA; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WEIGHT GAIN;

MUS;

EID: 46749092580     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10554     Document Type: Article

References (49)

1. Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR. 1998. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J Cell Sci 111(Pt 22):3311-3322.
2. Bertazzi PA, Zocchetti C, Guercilena S, Consonni D, Tironi A, Landi MT, et al. 1997. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident." Epidemiology 8:646-652.
3. Brodie AE, Azarenko VA, Hu CY. 1996. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of fat cell differentiation. Toxicol Lett 84:55-59.
4. Brodie AE, Azarenko VA, Hu CY. 1997. Inhibition of increases of transcription factor mRNAs during differentiation of primary rat adipocytes by in vivo 2,3,7,8-tetrachlorodlibenzo-p-dioxin (TCDD) treatment Toxicol Lett 90:91-95.
5. Brouwer A, Longnecker MP, Birnbaum LS, Cogliano J, Kostyniak P, Moore J, et al. 1999. Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environ Health Perspect 107(suppl 4):639-649.
6. Calvert GM, Sweeney MH, Deddens J, Wall DK. 1999. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 56:270-276.
7. Choi W, Eum SY, Lee YW, Hennig B, Robertson LW, Toborek M. 2003. PCB 104-induced proinflammatory reactions in human vascular andothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci 75:47-56.
8. Codru N, Schymura MJ, Negoita S, Rej R, Carpenter DO. 2007. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 115:1442-1447.
9. Cranmer M, Louie S, Kennedy RH, Kern PA, Fonseca VA, 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 56:431-436.
10. Daugherty A, Manning MW, Cassis LA. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612.
11. Eum SY, Rha GB, Hennig B, Toborek M. 2006. c-Src is the primary signaling mediator of polychlorinated biphenyl-induced interleukin-8 expression in a human microvascular endothelial cell line. Toxicol Sci 92:311-320.
12. Flegal KM, Carroll MD, Ogden CL, Johnson CL. 2002. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727.
13. Goodwill MH, Lawrence DA, Seegal RF. 2007. Polychlorinated biphenyls induce proinflammatory cytokine release and dopaminergic dysfunction: protection in interleukin-6 knockout mice. J Neuroimmunol 183:125-132.
14. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109.433-438.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. 2006. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21:1-6.
16. Hanlon PR, Ganem LG, Cho YC, Yamamoto M, Jefcoate CR. 2003. AhR- and ERK-dependent pathways function synergistically to madiate 2,3,7,8-tatrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation. Toxicol Appl Pharmacol 189:11-27.
17. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. 2004. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850.
18. Hennig B, Hammock BD, Slim R, Toborek M, Saraswathi V, Robertson LW. 2002a. PCB-induced oxidative stress in endothelial cells: modulation by nutrients. Int J Hyg Environ Health 205:95-102.
19. Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE, et al. 2002b. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 181:174-183.
20. Hennig B, Reiterer G, Toborek M, Matveev SV, Daugherty A, Smart E, et al. 2005. Dietary fat interacts with PCBs to induce changes in lipid metabolism in mice deficient in low-density lipoprotein receptor. Environ Health Perspect 113:83-87.
21. Hennig B, Slim R, Toborek M, Robertson LW. 1999. Linoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells. J Biochem Mol Toxicol 13:83-91.
22. Jensen E, Egan S, Canady R, Bolger P. 2001. Dietary exposures to persistent organic pollutants. Toxicol Ind Health 17:157-162.
23. Kato N, Tani T, Yoshida A. 1980. Effect of dietary level of protein on liver microsomal drug-metabolizing enzymes, urinary ascorbic acid and lipid metabolism in rats fed PCB-containing diets. J Nutr 110:1688-1694.
24. Kimbrough RD. 1985. Laboratory and human studies on polychlorinated biphenyls (PCBs) and related compounds. Environ Health Perspect 59:99-106.
25. Kodavanti PR, Ward TR, Derr-Yellin EC, Mundy WR, Casey AC, Bush B, et al. 1998. Congener-specific distribution of polychlorinated biphenyls in brain regions, blood, liver, and fat of adult rats following repeated exposure to Aroclor 1254. Toxicol Appl Pharmacol 153:199-210.
26. Koss G, Mayer-Rogge D, Seubert S, Seubert A, Losekam M. 1993. 2,2′,3′,4,4′5,5_p,-Heptachlorobiphenyl (PCB 180) - on its toxicokinetics, biotransformation and porphyrinogenic action in female rats. Arch Toxicol 67:651-654.
27. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. 2007. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18(2-4):313-325.
28. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. 2005. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol-Heart Circ Physiol 288:H2031-H2041.
29. Lee DH, Jacobs DR Jr, Porta M. 2006. Could low-level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes? J Epidemiol Community Health 60:1006-1008.
30. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR Jr. 2007a. Association between serum concentrations of persistent organic pollutants and insulin resistance among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30:622-628.
31. Lee OH, Lee JK, Porta M, Steffes M, Jacobs DR Jr. 2007b. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50:1841-1851.
32. Lim EJ, Smart EJ, Toborek M, Hennig B. 2007. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am J Physiol Heart Circ Physiol 293:H3340-H3347.
33. Manning MW, Cassis LA, Daugherty A. 2003. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23:483-488.
34. Mullerova D, Kopecky J. 2006. White adipose tissue: storage and effector site for environmental pollutants. Physiol Res 56(4):375-381.
35. Nagaoka S, Miyazaki H, Aoyama Y, Yoshida A. 1990. Effects of dietary polychlorinated biphenyls on cholesterol catabolism in rats. Br J Nutr 64:161-169.
36. Ogden CL, Flegal KM, Carroll MD, Johnson CL. 2002. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288:1728-1732.
37. Phillips M, Enan E, Liu PC, Matsumura F. 1995. Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci 108(Pt 1):395-402.
38. Quazi S, Yokogoshi H, Yoshida A. 1983. Effect of dietary fiber on hypercholesterolemia induced by dietary PCB or cholesterol in rats. J Nutr 113:1109-1118.
39. Ramadass P, Mearareni P, Toborek M, Robertson LW, Hennig B 2003. Dietary flavanoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endotelial cells. Toxicol Sci 76:212-219.
40. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O. Histochemistry 97:493-497.
41. Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607.
42. Shimba S, Todoroki K, Aoyagi T, Tezuka M. 1998. Depletion of arylhydrocarbon receptor during adipose differentiation in 3T3-L1 cells. Biochem Biophys Res Commun 249:131-137.
43. Sipka S, Eum SY, Won Son K Shifen Xu, Gavalas V, Hennig B, et al. 2008. Oral administration of PCBs induces proinflammatory and prometastatic responses. Environ Toxicol Pharmacol 25:251-259.
44. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds, Toxicol Sci 93:223-241.
45. Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W. 2006. Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17:352-359.
46. Vogel CF, Nishimura N, Sciullo E, Wong P, Li W, Matsumura F. 2007. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem Biophys 461:t69-175.
47. Wassermann M, Wassermann D. 1979. Risk assessment in geographical occupational health. Geogr Med 9:8-27.
48. Wise LS, Green H. 1979. Participation at one isozyme of cytosolic glycerophosphate dohydrogenase in the adipose conversion of 3T3 cells. J Biol Chem 254:273-275.
49. Wyss PA, Muhlebach S, Bickel MH. 1986. Long-term pharmacokinetics of 2,2′,4,4′,5,5′-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass. Drug Metab Dispos 14:361-365.